Nuheara: Receives ethics approval to begin clinical trials

Nuheara Receives ethics approval to begin clinical trials

  • Nuheara (NUH) has received ethics approval from the Australian Hearing Human Research Ethics Committee (AHHREC) to commence its medical device clinical trial
  • The company has been working to develop multi-functional, personalised, intelligent hearing devices that augment a person’s hearing
  • The company said this supports its planned expansion into clinically tested and regulatory approved medical devices
  • The company Co-founder, Managing Director and CEO Justin Miller said National Acoustics Laboratories has now commenced recruiting for company’s medical device clinical trial
  • Recruitment has already begun for the trial, which the company says supports its planned expansion into clinically tested and regulatory approved medical devices
Steve Sam
Steve Sam
Steve Sam is a financial reporter, analyst, and commentator with a strong focus on banking technology, digital payments, and the future of financial services.

You May Also Like

Perpetuals Strengthens AI with Quantum Resilience as a Service

The new offering promises enhanced stability and security for fintech operations.Highlights: Perpetuals launches unique Quantum Resilience as a...

Revolut Introduces AI Assistant for Money Management

New feature aims to enhance personal finance management for users.Highlights: Revolut launches an AI assistant for better money...

Revolut Enhances Services with AI Assistant for Money Management

The new feature aims to simplify personal finance management for users.Highlights: Revolut launches AI assistant feature for usersNew...

ClearBank EU to Launch Stablecoins Including Euro Coin and USD Coin

New offerings aim to enhance digital transactions for fintech users.Highlights: ClearBank EU announces stablecoin offerings targeting fintech markets.Initial...